Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

Horizon Therapeutics Public Limited Company

HZNP•NASDAQ
Healthcare
Drug Manufacturers - General
$116.30
$0.00(0.00%)
U.S. Market is Open • 13:02

Horizon Therapeutics Public Limited Company (HZNP) Stock Overview

Explore Horizon Therapeutics Public Limited Company’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap26.6B
P/E Ratio51.10
EPS (TTM)$1.88
ROE0.11%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$166.21

HZNP Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Horizon Therapeutics Public Limited Company (HZNP) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $166.21.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 51.10 and a market capitalization of 26.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
N/A
Year-to-Date (YTD) Change
N/A
1-Year Change
N/A
3-Year Change
18.47%
5-Year Change
225.86%
All-Time (Max) Change
1171.04%

Contact Information

https://www.horizontherapeutics.com
353 1 772 2100
70 St. Stephen’s Green, Dublin, NaN, 2

Company Facts

21,900 Employees
IPO DateJul 28, 2011
CountryIE

Frequently Asked Questions